|
|
||||||||
Armed Forces Radiobiology Research Institute, Bethesda, Maryland
Johns Hopkins Hospital, Baltimore, Maryland
Correspondence: For reprints contact: Lt. Hamilton, Armed Forces Radiobiology Research Institute, Bethesda, MD 20014.
ABSTRACT
Red blood cells (RBCs) labeled in vivo with 99mTcO4 have recently been recommended for blood-pool imaging, but the optimum conditions for in vivo labeling of RBCs have not been clearly defined. We therefore evaluated several stannous-ion preparations and stannous-ion concentrations to determine which provided the best labeling. The effect of the time interval between the Sn(II) and 99mTcO4 injections and the effect of carrier technetium on labeling efficiency were also studied. Maximal in vivo labeling efficiency was obtained using an intravenous dose of 10 µg Sn(II)/kg followed 530 min later by an injection of 99mTcO4. Neither the chelated form of stannous ion used in these studies nor the amount of carrier present had a significant effect on labeling efficiency. The biologic half-time of Tc-99m RBCs labeled in vivo was similar to that of Tc-99m RBCs labeled in vitro. In vivo labeling is a rapid and efficient method for the preparation of Tc-99m RBCs.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |